Henk Viëtor | MD, PhD | Chief Technology Officer
Henk is entrepreneur in the Life Sciences. He obtained his PhD studying the fetal immune system (LUMC – Leiden) and specialised in transfusion medicine (LUMC), immunology (LUMC) and clinical genetics (Radboud UMC – Nijmegen). In 2000 he became active as an entrepreneur in the Life Sciences industry. He was involved in the founding of 20 biotechnology startups, most of which were in the field of personalized medicine. These companies include Drug Discovery Factory, Oncodrone, Hercules Pharmaceuticals, Essential IP, Skyline Diagnostics, DCPrime, Immunaffect, Recharge, DC4U, and Mylife Technologies. He fulfilled numerous governance positions in, among others, the Centre for Translational Moleculair Medicine (CTMM), Biofarmind, HollandBio, Skyline Diagnostics and Lygature.